ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ICU vs CNSY // NET PROFIT MARGIN

SeaStar Medical Holding Corporation (NASDAQ) VS. Cerenome Inc. (NASDAQ) • 15-METRIC TALLY: ICU 2 — CNSY 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ICU VS. CNSY) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ICU CNSY SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 95.70% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin ACTIVE -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 180.00% -10.50% +190.50 ICU /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 2/9 +2.00 ICU /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 35.4 43.2 -7.80 CNSY /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $12.2M $13.2M -$1.1M CNSY /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ICU REV CNSY REV ICU GROSS % CNSY GROSS % ICU FCF CNSY FCF
FY 2025 $1.2M $5.2M 95.7% — -$13.6M -$20.8M
FY 2024 $135.0K $5.8M 98.0% — -$16.0M -$10.7M
FY 2023 $0 $4.9M — — -$10.3M -$12.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ICU // BETA —
CNSY // BETA —